Polar Light Ventures
Providing investment to early-stage companies backed by strong entrepreneurs
Polar Light Ventures
Polar Light Ventures focuses on Seed Stage
Technology Investments in Europe and the US, with outstanding entrepreneurs and highly scalable business models.
Polar Light Ventures focuses on Seed Stage
Technology Investments in Europe and the US, with outstanding entrepreneurs and highly scalable business models.
We actively support our founders
and portfolio companies to
achieve their goals by
leveraging our extensive
global network
What’s new in our portfolio
Nice recommends first AI medical device for skin cancer diagnosis in the NHS
LONDON, May. 1, 2025 (Pharma Times) — NICE has endorsed DERM, an autonomous AI medical device developed by Skin Analytics, for detecting skin cancer. This recognition marks a major step in using AI to free up clinician capacity and improve patient outcomes across the NHS…
Biosplice Announces First Patient Dosed in Phase 2 Trial of Cirtuvivint for Advanced Soft-Tissue Sarcomas
SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) — Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering advancements in small molecule inhibition of CDC-like kinases (CLK) and Dual-specificity tyrosine phosphorylation-regulated (DYRK) kinases, today announced…
Bitcoin Miner GDA Expands West Texas Facilities With 50 MW Deployment
HOUSTON, February 26, 2025 (Coindesk) – Genesis Digital Assets Limited (GDA) is expanding its bitcoin (BTC) mining operations in West Texas with a 50-megawatt (MW) energization increase across its Pyote and Vernon sites…
Fresha Accelerates European Expansion with New Offices in Madrid, Paris, and the Netherlands
LONDON, Feb. 27, 2025 /PRNewswire/ — Fresha, the world’s most popular beauty and wellness booking platform, today announced the opening of new offices in Madrid, Paris, and the Netherlands…